Latest Insider Transactions at Blueprint Medicines Corp (BPMC)
This section provides a real-time view of insider transactions for Blueprint Medicines Corp (BPMC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Blueprint Medicines Corp to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Blueprint Medicines Corp's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 12
2025
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
7,500
-2.37%
|
$652,500
$88.0 P/Share
|
|
Mar 12
2025
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
7,500
+4.48%
|
$270,000
$36.05 P/Share
|
|
Mar 06
2025
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,232
-7.63%
|
$455,184
$87.7 P/Share
|
|
Mar 05
2025
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
5,766
-3.78%
|
$507,408
$88.8 P/Share
|
|
Mar 05
2025
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,863
-12.0%
|
$427,944
$88.8 P/Share
|
|
Mar 05
2025
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,326
-7.26%
|
$116,688
$88.8 P/Share
|
|
Mar 05
2025
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,284
-6.76%
|
$464,992
$88.8 P/Share
|
|
Mar 05
2025
|
Philina Lee CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
3,733
-8.16%
|
$328,504
$88.8 P/Share
|
|
Mar 05
2025
|
Tracey L Mc Cain EVP AND CHIEF LEGAL OFFICER |
SELL
Open market or private sale
|
Direct |
5,262
-7.32%
|
$463,056
$88.8 P/Share
|
|
Mar 05
2025
|
Fouad Namouni PRESIDENT, R & D |
SELL
Open market or private sale
|
Direct |
6,489
-7.89%
|
$571,032
$88.8 P/Share
|
|
Mar 05
2025
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
6,495
-8.32%
|
$571,560
$88.8 P/Share
|
|
Mar 05
2025
|
Percy H. Carter CHIEF SCIENTIFIC OFFICER |
SELL
Open market or private sale
|
Direct |
3,530
-5.84%
|
$310,640
$88.8 P/Share
|
|
Mar 05
2025
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
SELL
Open market or private sale
|
Direct |
5,157
-9.42%
|
$453,816
$88.8 P/Share
|
|
Mar 05
2025
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
16,151
-8.75%
|
$1,421,288
$88.8 P/Share
|
|
Mar 03
2025
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
3,203
-3.17%
|
$294,676
$92.23 P/Share
|
|
Mar 01
2025
|
Tracey L Mc Cain EVP AND CHIEF LEGAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+13.28%
|
-
|
|
Mar 01
2025
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
6,506
+23.25%
|
-
|
|
Mar 01
2025
|
Philina Lee CHIEF COMMERCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+19.39%
|
-
|
|
Mar 01
2025
|
L. Becker Hewes CHIEF MEDICAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+21.35%
|
-
|
|
Mar 01
2025
|
Debra Durso Bumpus CHIEF PEOPLE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+16.73%
|
-
|
|
Mar 01
2025
|
Fouad Namouni PRESIDENT, R & D |
BUY
Grant, award, or other acquisition
|
Direct |
13,200
+13.83%
|
-
|
|
Mar 01
2025
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+12.33%
|
-
|
|
Mar 01
2025
|
Percy H. Carter CHIEF SCIENTIFIC OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
11,000
+15.41%
|
-
|
|
Mar 01
2025
|
Christina Rossi CHIEF OPERATING OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
13,200
+14.47%
|
-
|
|
Mar 01
2025
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
35,200
+16.02%
|
-
|
|
Feb 20
2025
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,274
-3.39%
|
$216,030
$95.14 P/Share
|
|
Jan 21
2025
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
1,446
-0.96%
|
$159,060
$110.24 P/Share
|
|
Jan 21
2025
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
15,161
-3.09%
|
$1,652,549
$109.88 P/Share
|
|
Jan 21
2025
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.63%
|
$360,000
$36.05 P/Share
|
|
Jan 21
2025
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,274
-0.83%
|
$250,140
$110.39 P/Share
|
|
Jan 13
2025
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
5,000
-3.08%
|
$510,000
$102.28 P/Share
|
|
Jan 13
2025
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.98%
|
$180,000
$36.05 P/Share
|
|
Jan 13
2025
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
2,250
-13.07%
|
$225,000
$100.0 P/Share
|
|
Jan 13
2025
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
2,250
+11.56%
|
$81,000
$36.05 P/Share
|
|
Dec 19
2024
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
15,000
-2.25%
|
$1,350,000
$90.1 P/Share
|
|
Dec 19
2024
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
15,000
+8.0%
|
$540,000
$36.05 P/Share
|
|
Dec 18
2024
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,274
-1.59%
|
$218,304
$96.19 P/Share
|
|
Dec 12
2024
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct |
1,819
-5.56%
|
$169,167
$93.43 P/Share
|
|
Dec 12
2024
|
Ariel Hurley PRINCIPAL ACCOUNTING OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,600
+8.7%
|
$24,000
$15.01 P/Share
|
|
Nov 29
2024
|
Kate Haviland CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct |
2,353
-0.51%
|
$225,888
$96.63 P/Share
|
|
Nov 27
2024
|
Christina Rossi CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct |
2,274
-3.08%
|
$216,030
$95.1 P/Share
|
|
Nov 21
2024
|
Lonnel Coats |
SELL
Open market or private sale
|
Direct |
9,824
-81.42%
|
$923,456
$94.87 P/Share
|
|
Nov 20
2024
|
Lonnel Coats |
SELL
Open market or private sale
|
Direct |
10,000
-17.41%
|
$940,000
$94.13 P/Share
|
|
Nov 20
2024
|
Lonnel Coats |
BUY
Exercise of conversion of derivative security
|
Direct |
8,812
+16.08%
|
$643,276
$73.01 P/Share
|
|
Nov 07
2024
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
5,000
-3.08%
|
$510,000
$102.0 P/Share
|
|
Nov 07
2024
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+2.98%
|
$180,000
$36.05 P/Share
|
|
Oct 03
2024
|
Fouad Namouni PRESIDENT, R & D |
SELL
Open market or private sale
|
Direct |
3,633
-5.0%
|
$323,337
$89.32 P/Share
|
|
Sep 09
2024
|
Jeffrey W. Albers |
SELL
Open market or private sale
|
Direct |
19,702
-5.72%
|
$1,674,670
$85.49 P/Share
|
|
Sep 09
2024
|
Jeffrey W. Albers |
BUY
Exercise of conversion of derivative security
|
Direct |
10,000
+5.34%
|
$360,000
$36.05 P/Share
|
|
Aug 15
2024
|
Michael Landsittel CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
4,409
-6.16%
|
$418,855
$95.23 P/Share
|